Leukapheresis Market – industry analysis and forecast (2019-2026) – by type, application, end user, and region

Leukapheresis Market – industry analysis and forecast (2019-2026) – by type, application, end user, and region

Market Scenario

Leukapheresis Market is expected to reach US$ XX Bn by 2026 at a CAGR of 7.5% during the forecast period. Leukapheresis Market Leukapheresis is a laboratory procedure in which white blood cells are separated from a sample of blood. It is a specific type of apheresis, the more general term for separating out one particular constituent of blood and returning the remaining part to the circulation. Rising incidence and prevalence of leukemia, growing demand for leukopaks, and the increasing number of blood donations would drive the market growth rate for leukapheresis. However, it is the high cost of leukopaks and therapeutic leukapheresis, complications associated with therapeutic leukapheresis and the stringent regulations for leukocyte donor recruitment that may hamper the market growth of leukapheresis. Leukapheresis market is segmented by type, application, end user, and region. Among application, the research application segment market accounted for the XX% share in 2018 due to increasing adoption of leukapheresis for the isolation of WBCs and development of cell-based immunotherapies. Among regions, North America and Europe are expected to hold a XX% market share during the forecast period due to increasing the number of blood donations, rising incidence, and prevalence of leukaemia and growing demand for leukopaks in clinical research. The Asia Pacific is expected to grow at the XX% CAGR during the forecast period due increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the presence of leading pharma and biotech companies, and improvement in healthcare access. The production players focus on mergers and collaborations, strategic partnerships, as well as innovative technological product launches to expand their business product portfolio as main strategies. There is a sturdy growth in the production as new companies are entering the leukapheresis market. For example, in May 2017, a leading medical devices company, Fresenius (Germany), announced its expanded production for medical devices in Haina, Dominican Republic (US). The Haina plant manufactures and exports apheresis systems for plasma and platelet collection as well as medical devices for blood separation. In the leukapheresis market, Terumo BCT (US) holds the leadership position due to advancing surgical innovation, production capacity expansion, brand portfolio expansion, mergers, collaborations, and acquisitions. In 2018, the company has adopted new product launches, product enhancements, and geographic expansion as its crucial business plans to certify its dominance in this market. The objective of the report is to present comprehensive analysis of leukapheresis market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding leukapheresis market dynamics, structure by analyzing the market segments, and project the leukapheresis market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the leukapheresis market make the report investor’s guide.

The scope of the leukapheresis Market report:

Leukapheresis Products Market, By Type

• Leukapheresis Devices o Apheresis Devices o Leukapheresis Columns & Cell Separators o Leukoreduction Filters • Leukapheresis Disposables

Leukapheresis Products Market, By Application

• Research Applications • Therapeutic Applications

Leukapheresis Products Market, By End User

• Blood Component Providers and Blood Centers • Academic and Research Institutes • Pharmaceutical and Biotechnology Companies • Hospitals and Transfusion Centers

Leukapheresis Market,By Region

• North America • Europe • APAC • Latin America • MEA

Key Players in Leukapheresis Market

• Asahi Kasei Medical • Haemonetics • Terumo BCT • STEMCELL Technologies • Macopharma • Fresenius • HemaCare • Caltag Medsystem • AllCells • StemExpress • PPA Research Group • Key Biologics • ZenBio • Precision for Medicine • BioIVT Interventional Cardiology Devices Market

Table of Contents

Leukapheresis Market

1. INTRODUCTION 1.1 Report Description 1.1.1 Objectives of the Study 1.1.2 Market Scope 1.1.3 Years considered in the study 1.1.4 Currency 1.1.5 Stakeholders 1.2 Target Audience 1.3 Key Takeaways 2. RESEARCH METHODOLOGY 2.1 Research Methodology 2.2 Market Definition 2.3 Assumptions and Acronyms Used 2.4 Data Sources 2.4.1 Secondary 2.4.1.1 Paid 2.4.1.2 Unpaid 2.4.2 Primary 2.5 Analyst tools and models 3. EXECUTIVE SUMMARY 3.1 Leukapheresis Market Overview 3.1.1 Leukapheresis Market : By Type 3.1.2 Leukapheresis Market : By Application 3.1.3 Leukapheresis Market : By End users 3.1.4 Leukapheresis Market : By Region 4. LEUKAPHERESIS MARKET OUTLOOK 4.1 Leukapheresis Market : Market Definition, Segmentation and Scope of Study 4.2 Leukapheresis Market : Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Leukapheresis Market : Competitive Analysis 4.3.1 Key Strategic Initiatives 4.3.2 Regional Presence 4.3.3 Product Overview 4.4 Leukapheresis Market : Porter’s Analysis 4.5 Leukapheresis Market : PESTEL Analysis 4.6 Leukapheresis Market : Product Benchmark Analysis 4.7 Leukapheresis Market : Company Market Share Analysis 4.8 Leukapheresis Market : Key Findings 4.8.1 Leukapheresis Market : Top Wining Strategies 4.8.2 Leukapheresis Market : Top Investment Pockets 4.8.3 Leukapheresis Market : Top Impacting Factors 5. LEUKAPHERESIS MARKET, BY TYPE 5.1 Leukapheresis Market : Type segment Market Share analysis 5.2 Leukapheresis Market : Type segment Market Size and Forecast 2019-2027 5.3 Leukapheresis Market by Leukapheresis Devices 5.4 Leukapheresis Market by Leukapheresis Disposables 5.5 Leukapheresis Market Benchmarking By Type 5.6 Leukapheresis Market by Type : Key Trends 5.7 Leukapheresis Market by Type : Key Developments 6. LEUKAPHERESIS MARKET , BY APPLICATION 6.1 Leukapheresis Market : application segment Market Share Analysis 6.2 LEUKAPHERESIS MARKET : application segment Market Size and Forecast 2019-2027 6.3 Leukapheresis Market by Research Applications 6.4 Leukapheresis Market by Therapeutic Applications 6.5 Leukapheresis Market Benchmarking By Application 6.6 Leukapheresis Market by Application: Key Trends 6.7 Leukapheresis Market by Application: Key Developments 7. LEUKAPHERESIS MARKET, BY END USERS 7.1 Leukapheresis Market : End users segment Market Share analysis 7.2 Leukapheresis Market : End users segment Market Size and Forecast 2019-2027 7.3 Leukapheresis Market by Blood Component Providers and Blood Centers 7.4 Leukapheresis Market by Academic and Research Institutes 7.5 Leukapheresis Market by Pharmaceutical and Biotechnology Companies 7.6 Leukapheresis Market by Hospitals and Transfusion Centers 7.7 Leukapheresis Market Benchmarking By End users 7.8 Leukapheresis Market by End users: Key Trends 7.9 Leukapheresis Market by End users: Key Developments 8. LEUKAPHERESIS MARKET , BY GEOGRAPHY 8.1 Leukapheresis Market : Market Share Analysis 8.2 Leukapheresis Market : Market Size and Forecast 2019-2027 8.3 North America 8.3.1 Overview 8.3.2 Leukapheresis Market Size and Forecast, by Type 2019-2027 8.3.3 Leukapheresis Market Share Analysis , by Type 2019-2027 8.3.4 Leukapheresis Market Size and Forecast, by Application 2019-2027 8.3.5 Leukapheresis Market Share Analysis , by Application 2019-2027 8.3.6 Leukapheresis Market Size and Forecast, by End users 2019-2027 8.3.7 Leukapheresis Market Share Analysis , by End users 2019-2027 8.4 Europe 8.4.1 Overview 8.4.2 Leukapheresis Market Size and Forecast, by Type 2019-2027 8.4.3 Leukapheresis Market Share Analysis , by Type 2019-2027 8.4.4 Leukapheresis Market Size and Forecast, by Application 2019-2027 8.4.5 Leukapheresis Market Share Analysis , by Application 2019-2027 8.4.6 Leukapheresis Market Size and Forecast, by End users 2019-2027 8.4.7 Leukapheresis Market Share Analysis , by End users 2019-2027 8.5 Asia Pacific 8.5.1 Overview 8.5.2 Leukapheresis Market Size and Forecast, by Type 2019-2027 8.5.3 Leukapheresis Market Share Analysis , by Type 2019-2027 8.5.4 Leukapheresis Market Size and Forecast, by Application 2019-2027 8.5.5 Leukapheresis Market Share Analysis , by Application 2019-2027 8.5.6 Leukapheresis Market Size and Forecast, by End users 2019-2027 8.5.7 Leukapheresis Market Share Analysis , by End users 2019-2027 8.6 Latin America, Middle East and Africa 8.6.1 Overview 8.6.2 Leukapheresis Market Size and Forecast, by Type 2019-2027 8.6.3 Leukapheresis Market Share Analysis , by Type 2019-2027 8.6.4 Leukapheresis Market Size and Forecast, by Application 2019-2027 8.6.5 Leukapheresis Market Share Analysis , by Application 2019-2027 8.6.6 Leukapheresis Market Size and Forecast, by End users 2019-2027 8.6.7 Leukapheresis Market Share Analysis , by End users 2019-2027 8.7 Leukapheresis Market Benchmarking By Geography 8.8 Leukapheresis Market by Geography : Key Trends 8.9 Leukapheresis Market by Geography : Key Developments 9. COMPITITIVE LANDSCAPE 9.1 Leukapheresis Market Share/ Positioning Analysis 9.2 Leukapheresis Market: Key Innovators 9.3 Leukapheresis Market : Company Profiles 9.3.1 Asahi Kasei Medical 9.3.1.1 Overview 9.3.1.2 Product/Service Portfolio 9.3.1.3 Key Financials 9.3.1.4 Strategic Initiatives 9.3.1.5 SWOT Analysis 9.3.1.6 Competitive Assessment 9.3.2 Haemonetics 9.3.2.1 Overview 9.3.2.2 Product/Service Portfolio 9.3.2.3 Key Financials 9.3.2.4 Strategic Initiatives 9.3.2.5 SWOT Analysis 9.3.2.6 Competitive Assessment 9.3.3 Terumo BCT 9.3.3.1 Overview 9.3.3.2 Product/Service Portfolio 9.3.3.3 Key Financials 9.3.3.4 Strategic Initiatives 9.3.3.5 SWOT Analysis 9.3.3.6 Competitive Assessment 9.3.4 STEMCELL Technologies 9.3.4.1 Overview 9.3.4.2 Product/Service Portfolio 9.3.4.3 Key Financials 9.3.4.4 Strategic Initiatives 9.3.4.5 SWOT Analysis 9.3.4.6 Competitive Assessment 9.3.5 Macopharma 9.3.5.1 Overview 9.3.5.2 Product/Service Portfolio 9.3.5.3 Key Financials 9.3.5.4 Strategic Initiatives 9.3.5.5 SWOT Analysis 9.3.5.6 Competitive Assessment 9.3.6 Fresenius 9.3.6.1 Overview 9.3.6.2 Product/Service Portfolio 9.3.6.3 Key Financials 9.3.6.4 Strategic Initiatives 9.3.6.5 SWOT Analysis 9.3.6.6 Competitive Assessment 9.3.7 HemaCare 9.3.7.1 Overview 9.3.7.2 Product/Service Portfolio 9.3.7.3 Key Financials 9.3.7.4 Strategic Initiatives 9.3.7.5 SWOT Analysis 9.3.7.6 Competitive Assessment 9.3.8 Caltag Medsystem 9.3.8.1 Overview 9.3.8.2 Product/Service Portfolio 9.3.8.3 Key Financials 9.3.8.4 Strategic Initiatives 9.3.8.5 SWOT Analysis 9.3.8.6 Competitive Assessment 9.3.9 AllCells 9.3.9.1 Overview 9.3.9.2 Product/Service Portfolio 9.3.9.3 Key Financials 9.3.9.4 Strategic Initiatives 9.3.9.5 SWOT Analysis 9.3.9.6 Competitive Assessment 9.3.10 StemExpress 9.3.10.1 Overview 9.3.10.2 Product/Service Portfolio 9.3.10.3 Key Financials 9.3.10.4 Strategic Initiatives 9.3.10.5 SWOT Analysis 9.3.10.6 Competitive Assessment 9.3.11 PPA Research Group 9.3.11.1 Overview 9.3.11.2 Product/Service Portfolio 9.3.11.3 Key Financials 9.3.11.4 Strategic Initiatives 9.3.11.5 SWOT Analysis 9.3.11.6 Competitive Assessment 9.3.12 Key Biologics 9.3.12.1 Overview 9.3.12.2 Product/Service Portfolio 9.3.12.3 Key Financials 9.3.12.4 Strategic Initiatives 9.3.12.5 SWOT Analysis 9.3.12.6 Competitive Assessment 9.3.13 ZenBio 9.3.13.1 Overview 9.3.13.2 Product/Service Portfolio 9.3.13.3 Key Financials 9.3.13.4 Strategic Initiatives 9.3.13.5 SWOT Analysis 9.3.13.6 Competitive Assessment 9.3.14 Precision for Medicine 9.3.14.1 Overview 9.3.14.2 Product/Service Portfolio 9.3.14.3 Key Financials 9.3.14.4 Strategic Initiatives 9.3.14.5 SWOT Analysis 9.3.14.6 Competitive Assessment 9.3.15 BioIVT 9.3.15.1 Overview 9.3.15.2 Product/Service Portfolio 9.3.15.3 Key Financials 9.3.15.4 Strategic Initiatives 9.3.15.5 SWOT Analysis 9.3.15.6 Competitive Assessment 10. CONSOLIDATION 10.1 Leukapheresis Market: Mergers and Acquisitions 10.1.1 Overview 10.1.2 Leukapheresis Market : Key Drivers – By Region 10.1.3 Leukapheresis Market : M&A Breakdown 10.1.3.1 Type Based 10.1.3.2 Application Based 10.1.3.3 End Users Based 10.1.3.4 Niche Based 10.1.3.5 Region Based 10.1.3.6 Asset & Non-Asset Based 10.1.3.7 Venture Capitalist Based 10.2 Fragmentation of Leukapheresis Market 10.3 Leukapheresis Market : Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 10.4 Leukapheresis Market - New/Emerging Models of Partnerships : Key Examples 10.5 Leukapheresis Market : New/Emerging Business Models : Key Examples 10.6 Leukapheresis Market - Changing Investment Paradigm : Focused areas by Key Players 10.7 Leukapheresis Market - Patent Analysis 11. Leukapheresis Market : LIST OF TABLES 12. Leukapheresis Market : LIST OF FIGURES

About This Report

Report ID13729
Category Medical Devices
Published Date
No of Pages311
Contact Us
Call Now